CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $24.90 million for the 12-month period ending 2020-12-26, per its 10-K filed 2021-02-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2021-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $24.90M, a 91.71% decline from fiscal 2019.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $300.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was -$800.00K, a 260.00% decline from fiscal 2017.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $500.00K, a 87.50% decline from fiscal 2016.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2020-12-26 | $24.90M 10-K · filed 2021-02-17 |
| 2019-12-28 | $300.20M 10-K · filed 2021-02-17 |
| 2018-12-29 | -$800.00K 10-K · filed 2019-02-13 |
| 2017-12-30 | $500.00K 10-K · filed 2018-02-13 |
| 2016-12-31 | $4.00M 10-K · filed 2017-02-14 |
| 2015-12-26 | -$200.00K 10-K · filed 2016-02-12 |
| 2014-12-27 | $1.21M 10-K · filed 2015-02-17 |
| 2013-12-28 | $433.00K 10-K · filed 2014-02-25 |
| 2012-12-29 | -$4.67M 10-K · filed 2013-02-27 |
| 2011-12-31 | $137.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |